tiprankstipranks
Advertisement
Advertisement
Cellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
PremiumCompany AnnouncementsCellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
2M ago
Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL
Premium
Company Announcements
Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL
2M ago
Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA
Premium
The Fly
Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA
2M ago
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
PremiumCompany AnnouncementsCellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
3M ago
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
Premium
The Fly
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
3M ago
Cellectis sees cash runway into 4Q27
Premium
The Fly
Cellectis sees cash runway into 4Q27
3M ago
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
PremiumCompany AnnouncementsCellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
3M ago
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
Premium
Company Announcements
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
4M ago
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
Premium
The Fly
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100